Combination therapy shows promise in fighting neuroblastoma

A study by a multidisciplinary team of researchers from The Saban Research Institute of Children's Hospital Los Angeles sheds further light on the role of the cytokine TGFβ1 in the growth of neuroblastoma, and suggests the possibility for a small molecule drug/antibody combinatorial therapy to treat this cancer.

Read more here: https://www.eurekalert.org/pub_releases/2016-10/chla-cts101116.php